One of the West Coast's largest real estate developers is moving full steam ahead on the next phase of a sprawling waterfront project in one of the nation's largest biotech hubs. The development, which is being built without a tenant in tow, bucks a trend of prominent Bay Area office projects that have been pushed to the back burner amid the coronavirus pandemic.
Kilroy To Make $900 Million Speculative Bet That Bay Area Biotech Boom Outlasts Pandemic
National Office Developer To Break Ground on Next Phase of Sprawling South San Francisco Development
By Katie Burke
CoStar News
May 5, 2021 | 2:01 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Phase II - Building D
363 Oyster Point Blvd, South San Francisco, CA
- East Tower
88 Bluxome St, San Francisco, CA
- Companies